BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16227207)

  • 1. Functional characterization of complement proteases C1s/mannan-binding lectin-associated serine protease-2 (MASP-2) chimeras reveals the higher C4 recognition efficacy of the MASP-2 complement control protein modules.
    Rossi V; Teillet F; Thielens NM; Bally I; Arlaud GJ
    J Biol Chem; 2005 Dec; 280(51):41811-8. PubMed ID: 16227207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate.
    Rossi V; Bally I; Thielens NM; Esser AF; Arlaud GJ
    J Biol Chem; 1998 Jan; 273(2):1232-9. PubMed ID: 9422791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2.
    Rossi V; Cseh S; Bally I; Thielens NM; Jensenius JC; Arlaud GJ
    J Biol Chem; 2001 Nov; 276(44):40880-7. PubMed ID: 11527969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2.
    Hor L; Pan J; Pike RN; Wijeyewickrema LC
    J Immunol; 2024 Apr; 212(7):1172-1177. PubMed ID: 38372634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.
    Ambrus G; Gál P; Kojima M; Szilágyi K; Balczer J; Antal J; Gráf L; Laich A; Moffatt BE; Schwaeble W; Sim RB; Závodszky P
    J Immunol; 2003 Feb; 170(3):1374-82. PubMed ID: 12538697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions.
    Harmat V; Gál P; Kardos J; Szilágyi K; Ambrus G; Végh B; Náray-Szabó G; Závodszky P
    J Mol Biol; 2004 Oct; 342(5):1533-46. PubMed ID: 15364579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly and enzymatic properties of the catalytic domain of human complement protease C1r.
    Lacroix M; Ebel C; Kardos J; Dobó J; Gál P; Závodszky P; Arlaud GJ; Thielens NM
    J Biol Chem; 2001 Sep; 276(39):36233-40. PubMed ID: 11445589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway.
    Vorup-Jensen T; Jensenius JC; Thiel S
    Immunobiology; 1998 Aug; 199(2):348-57. PubMed ID: 9777418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of the linker between the complement control protein modules of complement protease C1s.
    Bally I; Rossi V; Thielens NM; Gaboriaud C; Arlaud GJ
    J Immunol; 2005 Oct; 175(7):4536-42. PubMed ID: 16177097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction of early complement classical and lectin pathway activation
    Hurler L; Toonen EJM; Kajdácsi E; van Bree B; Brandwijk RJMGE; de Bruin W; Lyons PA; Bergamaschi L; ; Sinkovits G; Cervenak L; Würzner R; Prohászka Z
    Front Immunol; 2022; 13():1039765. PubMed ID: 36420270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serine protease domain of MASP-3: enzymatic properties and crystal structure in complex with ecotin.
    Gaboriaud C; Gupta RK; Martin L; Lacroix M; Serre L; Teillet F; Arlaud GJ; Rossi V; Thielens NM
    PLoS One; 2013; 8(7):e67962. PubMed ID: 23861840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2.
    Zundel S; Cseh S; Lacroix M; Dahl MR; Matsushita M; Andrieu JP; Schwaeble WJ; Jensenius JC; Fujita T; Arlaud GJ; Thielens NM
    J Immunol; 2004 Apr; 172(7):4342-50. PubMed ID: 15034049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of C1 and the MBL- and ficolin-MASP complexes: structural insights.
    Gaboriaud C; Teillet F; Gregory LA; Thielens NM; Arlaud GJ
    Immunobiology; 2007; 212(4-5):279-88. PubMed ID: 17544813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.
    Duncan RC; Bergström F; Coetzer TH; Blom AM; Wijeyewickrema LC; Pike RN
    Mol Immunol; 2012 Jan; 49(4):593-600. PubMed ID: 22071314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.
    Matsushita M; Fujita T
    J Exp Med; 1992 Dec; 176(6):1497-502. PubMed ID: 1460414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MASP1 (MBL-associated serine protease 1).
    Matsushita M; Endo Y; Fujita T
    Immunobiology; 1998 Aug; 199(2):340-7. PubMed ID: 9777417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes.
    Schwaeble W; Dahl MR; Thiel S; Stover C; Jensenius JC
    Immunobiology; 2002 Sep; 205(4-5):455-66. PubMed ID: 12396007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for activation of the complement system by component C4 cleavage.
    Kidmose RT; Laursen NS; Dobó J; Kjaer TR; Sirotkina S; Yatime L; Sottrup-Jensen L; Thiel S; Gál P; Andersen GR
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15425-30. PubMed ID: 22949645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.